CLEMENTIA PHARMACEUTICALS IN's ticker is CMTA and the CUSIP is 185575107. A total of 28 filers reported holding CLEMENTIA PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,235,000 | -29.7% | 105,000 | -33.3% | 0.05% | +10.9% |
| Q3 2018 | $1,756,000 | -12.8% | 157,500 | +2.9% | 0.05% | -4.2% |
| Q2 2018 | $2,013,000 | -26.2% | 153,001 | -15.0% | 0.05% | -44.2% |
| Q1 2018 | $2,727,000 | -24.4% | 180,000 | -5.3% | 0.09% | -7.5% |
| Q4 2017 | $3,606,000 | -37.6% | 190,000 | -44.5% | 0.09% | -56.5% |
| Q3 2017 | $5,781,000 | – | 342,256 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 222,000 | $2,611,000 | 2.47% |
| Orbimed Advisors | 10,425,225 | $122,601,000 | 2.27% |
| NEA Management Company, LLC | 2,707,734 | $31,843,000 | 1.26% |
| Perceptive Advisors | 1,500,000 | $17,640,000 | 0.67% |
| Opaleye Management Inc. | 150,000 | $1,764,000 | 0.66% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,008,001 | $11,854,000 | 0.51% |
| Artal Group S.A. | 850,000 | $9,996,000 | 0.37% |
| Baker Brothers Advisors | 3,724,445 | $43,799,000 | 0.36% |
| PFM Health Sciences, LP | 849,904 | $9,995,000 | 0.27% |
| Fosun International Ltd | 234,526 | $2,627,000 | 0.16% |